Envoy Medical Inc. (COCH) - Total Liabilities
Based on the latest financial reports, Envoy Medical Inc. (COCH) has total liabilities worth $15.71 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Envoy Medical Inc. to track the company's year-over-year net asset growth rate.
Envoy Medical Inc. - Total Liabilities Trend (2020–2024)
This chart illustrates how Envoy Medical Inc.'s total liabilities have evolved over time, based on quarterly financial data. See COCH FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Envoy Medical Inc. Competitors by Total Liabilities
The table below lists competitors of Envoy Medical Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Brite Tech Bhd
KLSE:0011
|
Malaysia | RM70.81 Million |
|
Shinpoong Pharmaceutical Co Ltd
KO:019175
|
Korea | ₩79.62 Billion |
|
BTC Health Ltd
AU:BTC
|
Australia | AU$248.95K |
|
Frtek Co.Ltd
KQ:073540
|
Korea | ₩10.01 Billion |
|
Bal Pharma Limited
NSE:BALPHARMA
|
India | Rs2.93 Billion |
|
Mr. Onion
TWO:2740
|
Taiwan | NT$43.17 Million |
|
DistIT AB (publ)
ST:DIST
|
Sweden | Skr394.40 Million |
|
Tomypak Holdings Bhd
KLSE:7285
|
Malaysia | RM130.42 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Envoy Medical Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Envoy Medical Inc..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Envoy Medical Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Envoy Medical Inc. (2020–2024)
The table below shows the annual total liabilities of Envoy Medical Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $30.38 Million | +202.38% |
| 2023-12-31 | $10.05 Million | -74.07% |
| 2022-12-31 | $38.75 Million | -18.56% |
| 2021-12-31 | $47.58 Million | +49625.69% |
| 2020-12-31 | $95.69K | -- |
About Envoy Medical Inc.
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; audi… Read more